| Literature DB >> 35822043 |
Belay Tessema1,2,3, Ulrich Sack1, Zoya Serebrovska4, Brigitte König2, Egor Egorov5.
Abstract
The effects of short-term hyperoxia on age-related diseases and aging biomarkers have been reported in animal and human experiments using different protocols; however, the findings of the studies remain conflicting. In this systematic review, we summarized the existing reports in the effects of short-term hyperoxia on age-related diseases, hypoxia-inducible factor 1α (HIF-1α), and other oxygen-sensitive transcription factors relevant to aging, telomere length, cellular senescence, and its side effects. This review was done as described in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. A systematic search was done in PubMed, Google Scholar, and Cochrane Library and from the references of selected articles to identify relevant studies until May 2021. Of the total 1,699 identified studies, 17 were included in this review. Most of the studies have shown significant effects of short-term hyperoxia on age-related diseases and aging biomarkers. The findings of the studies suggest the potential benefits of short-term hyperoxia in several clinical applications such as for patients undergoing stressful operations, restoration of cognitive function, and the treatment of severe traumatic brain injury. Short-term hyperoxia has significant effects in upregulation or downregulation of transcription factors relevant to aging such as HIF-1α, nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-kB), and nuclear factor (erythroid-derived 2)-like 2 (NRF2) among others. Short-term hyperoxia also has significant effects to increase antioxidant enzymes, and increase telomere length and clearance of senescent cells. Some of the studies have also reported adverse consequences including mitochondrial DNA damage and nuclear cataract formation depending on the dose and duration of oxygen exposure. In conclusion, short-term hyperoxia could be a feasible treatment option to treat age-related disease and to slow aging because of its ability to increase antioxidant enzymes, significantly increase telomere length and clearance of senescent cells, and improve cognitive function, among others. The reported side effects of hyperoxia vary depending on the dose and duration of exposure. Therefore, it seems that additional studies for better understanding the beneficial effects of short-term hyperoxia and for minimizing side effects are necessary for optimal clinical application.Entities:
Keywords: age-related diseases; aging; aging biomarkers; effects; hyperoxia
Year: 2022 PMID: 35822043 PMCID: PMC9261365 DOI: 10.3389/fragi.2021.783144
Source DB: PubMed Journal: Front Aging ISSN: 2673-6217
FIGURE 1PRISMA flow diagram shows the search strategy and screening of eligible studies at different levels of the review process (Moher et al., 2009).
The effect of hyperoxia on aging markers in human.
| Author, year | Condition | Age in years | Hyperoxia protocol | Aging markers | Results | Conclusion | Safety issues (oxygen toxicity) |
|---|---|---|---|---|---|---|---|
|
| Healthy | Adults (>64) | 100% O2 at 2ATA for 90 min with 5-min air breaks every 20 min | CBF | Increased | HBOT induces cognitive enhancements in healthy aging adults | Mild middle ear barotrauma, visual acuity changes, far sight acuity deterioration |
|
| Healthy | Adults (mean, 21) | 30% O2 (MH) for 1 h | HIF-1α | Activated | The return to normoxia after MH is sensed as a hypoxic trigger characterized by HIF-1 activation. On the contrary, HH and VHH induce a shift toward an oxidative stress response, characterized by NRF2 and NF- kB activation | Not reported |
| NRF2 | Activated | ||||||
| NF- kB | Not activated | ||||||
| GSH | Not activated | ||||||
| MMP-9 and MMP-2 | Activated (MMP-9) | ||||||
|
| Healthy | Adults (mean, 21) | 100% O2 (HH) for 1 h | HIF-1α | Activated | ||
| NRF2 | Activated | ||||||
| NF- kB | Activated | ||||||
| GSH | Activated | ||||||
| MMP-9 and MMP-2 | Activated | ||||||
|
| Healthy | Adults (mean, 21) | 140% O2 (VHH) for 1 h | HIF-1α | Not activated | ||
| NRF2 | Activated | ||||||
| NF- kB | Activated | ||||||
| GSH | Activated | ||||||
| MMP-9 and MMP-2 | Activated (MMP-9) | ||||||
|
| Colon cancer | Adults (18–80) | 30 or 80% O2 throughout surgery | MDA levels | Lower in the 80% O2 group than in the 30% O2 group | An increase in oxidative stress marker levels in blood and colonic mucosa occur when 30% O2 is used, possibly through an increase in XO enzymatic activity in the colonic mucosa. The 80% O2 prevented oxidative stress, with a reduction of lipid peroxidation and glutathione oxidation; this may be due to decreases in XO enzymatic activity and XO/(XO + XDH) ratio in the colonic mucosa | Authors could not find respiratory complications in their patients during the study period. Administration of 80% O2 during surgery and 2 h after surgery did not worsen pulmonary function or cause atelectasis |
| GSSG | Lower in the 80% O2 group than in the 30% O2 group | ||||||
| XDH | XDH was higher, but XO/(XO + XDH) ratio was lower in the 80% O2 group than in the 30% O2 group | ||||||
| XO | XO and XO/(XO + XDH) ratio were lower in the 80% O2 group than in the 30% O2 group | ||||||
|
| Healthy | Adults (>64) | 100% O2 at 2ATA for 90 min with 5-min air breaks every 20 min | Telomere length | Telomeres length of T helper, T cytotoxic, natural killer, and B cells increased | The study indicates that HBOT may induce significant senolytic effects including significantly increasing telomere length and clearance of senescent cells in the aging populations | Not reported |
| Senescent cells | Decrease in the number of senescent T helpers and T-cytotoxic senescent cells | ||||||
| HIF-1α | HIF-1 α levels increased | ||||||
|
| Coronary artery diseases | Adults (mean age >60) | >96% O2 for 120 min before cardioplegia | Troponin I | Did not differ between the groups | Exposure to >96% oxygen before cardioplegia did not attenuate ischemia–reperfusion injury of the heart in patients undergoing coronary artery bypass grafting. The only potentially beneficial effect observed was the decreased transmyocardial release of interleukin-6 | Not reported |
| CK-MB | Did not differ between the groups | ||||||
| Lactate | Did not differ between the groups | ||||||
| GSH | More oxidized GSH was released in the hyperoxia group | ||||||
| Il-6 | Decreased release of IL-6 | ||||||
|
| Coronary artery | Adults (>54) | 100% O2 for 60 min | MTRNR2L2 and MTRNR2L8 genes | MTRNR2L2 and MTRNR2L8 upregulated, and a “cell survival” network was activated | Administration of 100% oxygen for 1 h changes gene expression in the myocardium of the patients with coronary artery disease and may enhance cell survival capability | Not reported |
|
| Healthy | Adults (mean age 25.5) | 100% O2 for 2 h | EPO | EPO concentration was significantly lower in hyperbaric than in the normobaric condition | The increased O2 tension suppresses the production of EPO in 3–5 h after the hyperoxic breathing intervention | Not reported |
|
| Abdominal surgery | Adults (18+) | 80% O2 during the surgery and until 2 h after the end of surgery | Hydroperoxides | Hydroperoxides did not highlight any differences between the two groups nor within the same group, with respect to the baseline value | MDA, the main end product of the peroxidation of polyunsaturated fatty acids directly influenced by O2, may represent the best marker to assess the pro-oxidant/antioxidant equilibrium after surgery | Unbalanced pro-oxidant/antioxidant equilibrium |
| Antioxidants | Antioxidant defense lower, in the 80% O2 group with respect to both the 40% O2 group and the baseline values | ||||||
| NOx | NOx was higher in the 80% O2 group than the 40% O2 group at 2 h after surgery | ||||||
| MDA | The MDA concentration was higher 24 h after surgery in the 80% O2 group with respect to both the 40% O2 group and the baseline values | ||||||
| HbSSG | HbSSG in red blood cells was higher in the 80% O2 group at the end of the surgery | ||||||
|
| Severe traumatic brain injury | Adults (average, 35) | 100% O2 for 60 min at 1.5 ATA (HBO2) or 100% O2 for 3 h at 1.0 ATA (NBH) | CBF | Hyperbaric O2 significantly increased CBF for 6 h | Hyperbaric O2 has a more robust posttreatment effect than NBH on oxidative cerebral metabolism | No signs of pulmonary or cerebral O2 toxicity |
| CSF lactate, glucose, pyruvate, and glycerol level | CSF lactate concentrations decreased in both the HBO2 and NBH groups. The dialysate lactate levels in HBO2 decreased. Microdialysis lactate/pyruvate (L/P) ratios decreased in both HBO2 and NBH groups. No increase in microdialysate glycerol | ||||||
| CSF F2-isoprostane | No increase in the CSF F2-isoprostane levels | ||||||
| BAL fluid IL–8 and IL-6 | No increase in BAL inflammatory markers, IL-6, and IL-8 |
MH, Medium hyperoxia; HH, High hyperoxia; VHH, Very high hyperoxia; CBF, Cerebral blood flow: HIF-1 α, Hypoxia-inducible factor-1 α; NRF2, Nuclear factor (erythroid-derived 2)-like 2; NF- kB, Nuclear Factor kappa-light-chain-enhancer of activated B cells; GSH, Glutathione; MMP-9/2, Matrix metallopeptidase- 9/2; MDA, malondialdehyde; GSSG, oxidized glutathione; XDH, xanthine dehydrogenase; XO, xanthine oxidase; CK-MB, creatine kinase-MB; IL-6/8, interleukin-6/8; EPO, Erythropoietin; NOx, nitrates and nitrites; HbSSG, glutathionyl hemoglobin.
The effect of hyperoxia on aging markers in cell lines.
| Author and year | Cell line | Hyperoxia protocol | Aging markers | Results | Conclusion | Safety issues (oxygen toxicity) |
|---|---|---|---|---|---|---|
|
| HMEC-1 | 100% O2 at 2.4 ATA for 1 h | Antioxidant gene expression in Nrf2, Integrin, and ERK/MAPK pathways | The HSPA1A, HMOX1, and MT1X genes were upregulated, and collectively can provide protection from metabolic, proteotoxic, and oxidative forms of stress. ERK/MAPK signaling, including the activation of a number of immediate early genes can potentially influence apoptotic signaling. Endothelial cell viability in the HBO-treated cultures was significantly increased | The data indicate that hyperbaric oxygen can induce protection against oxidative insults in endothelial cells and may provide an easily administered hormetic treatment to help promote healthy aging | HBO is a relatively low-risk procedure that could be effectively applied as a broader preventative regimen to reduce the effects of aging |
|
| MEFs | 40% O2 for 2 weeks | Nrf2 signal transduction pathway | Hyperoxia increased baseline levels of Nrf2 and multiple transcriptional targets (20S Proteasome, Immunoproteasome, Lon protease, NQO1, and HO-1) | Changes the balance of Nrf2, Bach1, and c-Myc levels may account for dysregulation of stress responses and adaptive homeostasis during chronic hyperoxia and in aging | Not reported |
| Nrf2 inhibitors (Bach1 and c-Myc) | Bach1 and c-Myc were strongly elevated by hyperoxia and appeared to exert a ceiling on Nrf2 signaling. Bach1 and c-Myc also increase during aging and may thus be the mechanism by which adaptive homeostasis is compromised with age | |||||
| Cellular ability to adapt to signaling levels (1.0 μM) of H2O4 | Hyperoxia resulted in loss of cellular ability to adapt to signaling levels (1.0 μM) of H2O2 |
HMEC-1, Human microvascular endothelial cell line; MEFs, Mouse embryonic fibroblasts; HSPA1A, 70- kilodalton heat shock protein; HMOX1, heme oxygenase 1; MT1X, metallothionein 1X.
The effect of hyperoxia on aging markers in rats.
| Author and year | Condition | Age | Hyperoxia protocol | Aging markers | Results | Conclusion | Safety issues |
|---|---|---|---|---|---|---|---|
|
| Healthy | 4–14 days | >95% O2 for 10 days | VEGF | mRNA levels of VEGF increased in normoxic animals, but hyperoxia suppressed this increase | Hyperoxic exposure decreased VEGF levels, and decreased VEGF receptors (VEGFR1 and VEGFR2) levels | Not reported |
| VEGF receptors (VEGFR1 and EGFR2) | VEGFR1 and VEGFR2 mRNA increased in normoxic animals, but they were decreased by hyperoxia | ||||||
| HIF-2 α | mRNA levels of HIF-2 α increased in normoxic animals, but hyperoxia suppressed this increase | ||||||
|
| NA | >20 weeks | 100% O2 at 2 ATA for 80 min/day for 14 days | Synaptic plasticity [Markers: LTD, LTP, dendritic spine density, expression of synaptic protein (PSD 95)] | Synaptic plasticity was restored/improved | HBOT attenuated insulin resistance, cognitive impairment, hippocampal aging and pathologies. These findings suggest that HBOT restored insulin sensitivity, hippocampal functions, cognition in aging, and aging-obese models | Not reported |
| Hippocampal insulin receptor function (marker: LTD) | Insulin receptor function was restored/improved | ||||||
| Hippocampal ROS level | ROS was decreased | ||||||
| DCX | Could not restore neurogenesis | ||||||
| Hippocampal autophagy (markers: p62 and LC3-II) | Hippocampal autophagy was restored | ||||||
| Microglia hyperactivation | Microglial hyperactivation was attenuated | ||||||
| Hippocampal apoptosis | Hippocampal apoptosis reversed back to normal | ||||||
| Aging marker: beta-secretase (BACE1) | BACE1 enzyme was reduced | ||||||
| Aging marker: telomere length | Telomere length was restored | ||||||
| Aging marker: SA-β-gal staining | The number of SA-β-gal-positive cells was decreased | ||||||
|
| Healthy | 2–14 months | 60% O2 for 3 weeks | mtDNA damage | Increased | These data emphasize the importance of DNA repair enzymes and antioxidant enzymes as targets to promote DNA repair and reduce production of ROS. | Increasing the exposure of the lens to hyperoxia could lead to mtDNA damage and increase the risk of nuclear cataract formation |
| mtBER enzymes | Increased | ||||||
| 8-OHdG levels | Increased |
NM, not mentioned; VEGF, Vascular endothelial growth factor; LTD, Insulin-induced long-term depression; LTP, long-term potentiation; SA-β-gal, senescence-associated β falactosidase; DCFHDA, dichloro-hydrofluoresceindiacetate; DCX, neurogenesis; mtBER, mtDNA, base excision repair; mtDNA, mitochondrial DNA; LX-PCR, Long extension polymerase chain reaction; 8-OHdG, 8-hydroxy-20-deoxy-guanosine.
The effect of hyperoxia on aging markers in insects and worms.
| Author and year | Insect/worm | Condition | Age | Hyperoxia protocol | Aging markers | Results | Conclusion | Safety issues |
|---|---|---|---|---|---|---|---|---|
|
|
| NA | 9–59 days | 100% O2 from 10 days old until death | GSH | Hyperoxia had no marked effect on GSH concentration in both WT and YW flies | Results indicated that hyperoxia (100% oxygen) neither reproduces nor accelerates the pattern of alterations in glutathione redox state and PrSSG content observed during aging under normoxic conditions | Not reported |
| GSSG | Under hyperoxia, YW flies did not exhibit an increase in GSSG amount or a decline in GSH:GSSG ratio, whereas WT flies showed a decline in GSH:GSSG ratio only during the latter part of hyperoxia | |||||||
| PrSSG | In neither strain was there a progressive increase in PrSSG amount under hyperoxia | |||||||
|
|
| NA | 3–4 days old | 100% O2 was passed through the box at a constant rate (300 ml/min) | Degeneration of mitochondria | In hyperoxia condition, mitochondrial degeneration occurs rapidly within mitochondria of the flight muscle | Authors discovered a biomarker of oxidative damage to the mitochondria (swirls) within the flight muscle. Swirls may represent an early event in the deterioration of the mitochondrion | Degeneration of the mitochondria |
|
|
| NA | 5–15 days | 90% O2 for 3 h per day for 10 days | Mitochondrial superoxide radical (O2-) levels | The O2- levels in age 1 strain significantly decreased after intermittent hyperoxia exposure | These data suggest that oxidative stress-induced hormesis is associated with a reduction in mitochondrial O2- production by activation of the antioxidant system | Not reported |
NA, not applicable; GSH, Glutathione; GSSG, glutathione disulfide; PrSSG, protein mixed disulfides; O2, superoxide; Ins/IGF-1, Insulin/Insulin-like growth factor-1.